USF2 and chronic myelogenous leukemia, BCR-ABL1 positive: Restoring miR-10a-5p levels by miR-10a-5p mimic in these cells decreased USF2 expression, reduced cell proliferation, and enhanced apoptosis, suggesting a viable therapeutic strategy for CML [29].